Literature DB >> 19264867

Studies in mice deficient for the autoimmune regulator (Aire) and transgenic for the thyrotropin receptor reveal a role for Aire in tolerance for thyroid autoantigens.

Alexander V Misharin1, Yuji Nagayama, Holly A Aliesky, Basil Rapoport, Sandra M McLachlan.   

Abstract

The autoimmune regulator (Aire) mediates central tolerance for many autoantigens, and autoimmunity occurs spontaneously in Aire-deficient humans and mice. Using a mouse model of Graves' disease, we investigated the role of Aire in tolerance to the TSH receptor (TSHR) in Aire-deficient and wild-type mice (hyperthyroid-susceptible BALB/c background). Mice were immunized three times with TSHR A-subunit expressing adenovirus. The lack of Aire did not influence T-cell responses to TSHR protein or TSHR peptides. However, antibody levels were higher in Aire-deficient than wild-type mice after the second (but not the third) immunization. After the third immunization, hyperthyroidism persisted in a higher proportion of Aire-deficient than wild-type mice. Aire-deficient mice were crossed with transgenic strains expressing high or low-intrathyroidal levels of human TSHR A subunits. In the low-expressor transgenics, Aire deficiency had the same effect on the pattern of the TSHR antibody response to immunization as in nontransgenics, although the amplitude of the response was lower in the transgenics. High-expressor A-subunit transgenics were unresponsive to immunization. We examined intrathymic expression of murine TSHR, thyroglobulin, and thyroid peroxidase (TPO), the latter two being the dominant autoantigens in Hashimoto's thyroiditis (particularly TPO). Expression of the TSHR and thyroglobulin were reduced in the absence of Aire. Dramatically, thymic expression of TPO was nearly abolished. In contrast, the human A-subunit transgene, lacking a potential Aire-binding motif, was unaffected. Our findings provide insight into how varying intrathymic autoantigen expression may modulate thyroid autoimmunity and suggest that Aire deficiency may contribute more to developing Hashimoto's thyroiditis than Graves' disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264867      PMCID: PMC2689795          DOI: 10.1210/en.2008-1690

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  52 in total

1.  Alteration of intra-pancreatic target-organ specificity by abrogation of Aire in NOD mice.

Authors:  Shino Niki; Kiyotaka Oshikawa; Yasuhiro Mouri; Fumiko Hirota; Akemi Matsushima; Masashi Yano; Hongwei Han; Yoshimi Bando; Keisuke Izumi; Masaki Matsumoto; Keiichi I Nakayama; Noriyuki Kuroda; Mitsuru Matsumoto
Journal:  J Clin Invest       Date:  2006-04-20       Impact factor: 14.808

2.  A defect of regulatory T cells in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Authors:  Eliisa Kekäläinen; Heli Tuovinen; Joonas Joensuu; Mikhail Gylling; Rauli Franssila; Nora Pöntynen; Kimmo Talvensaari; Jaakko Perheentupa; Aaro Miettinen; T Petteri Arstila
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

3.  An improved Graves' disease model established by using in vivo electroporation exhibited long-term immunity to hyperthyroidism in BALB/c mice.

Authors:  Toshio Kaneda; Asako Honda; Atsushi Hakozaki; Tetsuya Fuse; Akihiro Muto; Tadashi Yoshida
Journal:  Endocrinology       Date:  2007-01-25       Impact factor: 4.736

4.  Role of amino acids 261-418 in proteolytic cleavage of the extracellular region of the human thyrotropin receptor.

Authors:  D Russo; Y Nagayama; G D Chazenbalk; H L Wadsworth; B Rapoport
Journal:  Endocrinology       Date:  1992-04       Impact factor: 4.736

Review 5.  The thyrotropin receptor in Graves' disease.

Authors:  Basil Rapoport; Sandra M McLachlan
Journal:  Thyroid       Date:  2007-10       Impact factor: 6.568

Review 6.  Graves' animal models of Graves' hyperthyroidism.

Authors:  Yuji Nagayama
Journal:  Thyroid       Date:  2007-10       Impact factor: 6.568

7.  The autoimmune regulator directly controls the expression of genes critical for thymic epithelial function.

Authors:  Qing-Guo Ruan; Kenneth Tung; Daniel Eisenman; Yulius Setiady; Sarah Eckenrode; Bing Yi; Sharad Purohit; Wei-Peng Zheng; Yan Zhang; Leena Peltonen; Jin-Xiong She
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

Review 8.  A decade of AIRE.

Authors:  Diane Mathis; Christophe Benoist
Journal:  Nat Rev Immunol       Date:  2007-07-20       Impact factor: 53.106

9.  Modulation of Aire regulates the expression of tissue-restricted antigens.

Authors:  Vivian Kont; Martti Laan; Kai Kisand; Andres Merits; Hamish S Scott; Pärt Peterson
Journal:  Mol Immunol       Date:  2007-06-28       Impact factor: 4.407

10.  An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus.

Authors:  Matthieu Giraud; Richard Taubert; Claire Vandiedonck; Xiayi Ke; Matthieu Lévi-Strauss; Franco Pagani; Francisco E Baralle; Bruno Eymard; Christine Tranchant; Philippe Gajdos; Angela Vincent; Nick Willcox; David Beeson; Bruno Kyewski; Henri-Jean Garchon
Journal:  Nature       Date:  2007-08-08       Impact factor: 49.962

View more
  19 in total

Review 1.  Review and hypothesis: does Graves' disease develop in non-human great apes?

Authors:  Sandra M McLachlan; Kristine Alpi; Basil Rapoport
Journal:  Thyroid       Date:  2011-11-08       Impact factor: 6.568

2.  High-level intrathymic thyrotrophin receptor expression in thyroiditis-prone mice protects against the spontaneous generation of pathogenic thyrotrophin receptor autoantibodies.

Authors:  S M McLachlan; H A Aliesky; B Banuelos; S Lesage; R Collin; B Rapoport
Journal:  Clin Exp Immunol       Date:  2017-02-20       Impact factor: 4.330

3.  Activation-induced cell death of self-reactive regulatory T cells drives autoimmunity.

Authors:  Ester Badami; Olivier N F Cexus; Sonia Quaratino
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-09       Impact factor: 11.205

4.  An attempt to induce "Graves' disease of the gonads" by immunizing mice with the luteinizing hormone receptor provides insight into breaking tolerance to self-antigens.

Authors:  Chun-Rong Chen; Holly A Aliesky; Basil Rapoport; Sandra M McLachlan
Journal:  Thyroid       Date:  2011-06-07       Impact factor: 6.568

5.  Role of self-tolerance and chronic stimulation in the long-term persistence of adenovirus-induced thyrotropin receptor antibodies in wild-type and transgenic mice.

Authors:  Sandra M McLachlan; Holly A Aliesky; Chun-Rong Chen; Basil Rapoport
Journal:  Thyroid       Date:  2012-07-24       Impact factor: 6.568

Review 6.  Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

Review 7.  A transgenic mouse that spontaneously develops pathogenic TSH receptor antibodies will facilitate study of antigen-specific immunotherapy for human Graves' disease.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocrine       Date:  2019-09-27       Impact factor: 3.633

8.  Altered expression of autoimmune regulator in infant down syndrome thymus, a possible contributor to an autoimmune phenotype.

Authors:  Gabriel Skogberg; Vanja Lundberg; Susanne Lindgren; Judith Gudmundsdottir; Kerstin Sandström; Olle Kämpe; Göran Annerén; Jan Gustafsson; Jan Sunnegårdh; Sjoerd van der Post; Esbjörn Telemo; Martin Berglund; Olov Ekwall
Journal:  J Immunol       Date:  2014-07-18       Impact factor: 5.422

9.  Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases.

Authors:  Nadine Dragin; Jacky Bismuth; Géraldine Cizeron-Clairac; Maria Grazia Biferi; Claire Berthault; Alain Serraf; Rémi Nottin; David Klatzmann; Ana Cumano; Martine Barkats; Rozen Le Panse; Sonia Berrih-Aknin
Journal:  J Clin Invest       Date:  2016-03-21       Impact factor: 14.808

Review 10.  Autoimmune thyroiditis: a model uniquely suited to probe regulatory T cell function.

Authors:  Yi-Chi M Kong; Gerald P Morris; Nicholas K Brown; Yan Yan; Jeffrey C Flynn; Chella S David
Journal:  J Autoimmun       Date:  2009-10-12       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.